Novel therapeutic strategy for stroke in rats by bone marrow stromal cells and ex vivo HGF gene transfer with HSV-1 vector. - Wikidata - wikimedia - TriplyDB

Novel therapeutic strategy for stroke in rats by bone marrow stromal cells and ex vivo HGF gene transfer with HSV-1 vector.

Novel therapeutic strategy for stroke in rats by bone marrow stromal cells and ex vivo HGF gene transfer with HSV-1 vector.

http://www.wikidata.org/entity/Q48682582

about

Cell based therapies for ischemic stroke: from basic science to bedside Cell-based therapy for acute organ injury: preclinical evidence and ongoing clinical trials using mesenchymal stem cells Sustained functional improvement by hepatocyte growth factor-like small molecule BB3 after focal cerebral ischemia in rats and mice.Angiogenesis, neurogenesis and brain recovery of function following injury Mesenchymal Stem Cells Overexpressing Interleukin-10 Promote Neuroprotection in Experimental Acute Ischemic Stroke.Iba1(+)/NG2(+) macrophage-like cells expressing a variety of neuroprotective factors ameliorate ischemic damage of the brain.Mesenchymal stem cells as therapeutics and vehicles for gene and drug delivery In vivo Tracking of Transplanted Bone Marrow-Derived Mesenchymal Stem Cells in a Murine Model of Stroke by Bioluminescence Imaging Mesenchymal stem cells at the intersection of cell and gene therapy.Human bone marrow-derived mesenchymal stem cells.The great migration of bone marrow-derived stem cells toward the ischemic brain: therapeutic implications for stroke and other neurological disorders Improving the Post-Stroke Therapeutic Potency of Mesenchymal Multipotent Stromal Cells by Cocultivation With Cortical Neurons: The Role of Crosstalk Between Cells Differential Migration of Mesenchymal Stem Cells to Ischemic Regions after Middle Cerebral Artery Occlusion in Rats.Bone marrow stem cell mobilization in stroke: a 'bonehead' may be good after all!Effects of Mesenchymal Stem Cell Treatment on the Expression of Matrix Metalloproteinases and Angiogenesis during Ischemic Stroke Recovery.Hypoxia-inducible factor 1-α-AA-modified bone marrow stem cells protect PC12 cells from hypoxia-induced apoptosis, partially through VEGF/PI3K/Akt/FoxO1 pathway.Viral caspase inhibitor p35, but not crmA, is neuroprotective in the ischemic penumbra following experimental stroke The Effect of CXCR4 Overexpression on Mesenchymal Stem Cell Transplantation in Ischemic Stroke.Neurorestorative treatment of stroke: cell and pharmacological approaches.Angiogenic cytokines in renovascular disease: do they have potential for therapeutic use?One cell, multiple roles: contribution of mesenchymal stem cells to tumor development in tumor microenvironment.Stem cell sources and therapeutic approaches for central nervous system and neural retinal disorders.Evidence for high translational potential of mesenchymal stromal cell therapy to improve recovery from ischemic stroke.The angiotensin II type 2 receptor in the brain.The role of astrocytes in mediating exogenous cell-based restorative therapy for stroke Biomolecule delivery to engineer the cellular microenvironment for regenerative medicine.Role of angiotensin II receptor subtype activation in cognitive function and ischaemic brain damage.Bone marrow stromal cells as a therapeutic treatment for ischemic stroke.Therapeutic potential of hepatocyte growth factor against cerebral ischemia (Review).Engineering Stem Cells for Biomedical Applications.Mesenchymal stem cells for ischemic stroke: changes in effects after ex vivo culturing.Introduction of hIGF-1 gene into bone marrow stromal cells and its effects on the cell's biological behaviors.Mesenchymal stem cells expressing brain-derived neurotrophic factor enhance endogenous neurogenesis in an ischemic stroke model.Stem cell-based therapies for ischemic stroke.Stem cell therapy for the systemic right ventricle.Therapeutic efficacy of bone marrow-derived mononuclear cells in diabetic polyneuropathy is impaired with aging or diabetes.Fibroblast Growth Factor 1-Transfected Adipose-Derived Mesenchymal Stem Cells Promote Angiogenic Proliferation.Vascular endothelial growth factor gene-transferred bone marrow stromal cells engineered with a herpes simplex virus type 1 vector can improve neurological deficits and reduce infarction volume in rat brain ischemia.Fibroblast Growth Factor Type 1 (FGF1)-Overexpressed Adipose-Derived Mesenchaymal Stem Cells (AD-MSCFGF1) Induce Neuroprotection and Functional Recovery in a Rat Stroke Model.Mesenchymal stromal cells rescue cortical neurons from apoptotic cell death in an in vitro model of cerebral ischemia.

P2860

Q27025754-A0C3A0C9-7231-40E7-ADC4-2BFEBABAF901 Q27026350-167CE6E6-2DAC-470A-9CB2-220F38F78EDE Q27321286-D27D114C-3821-44D3-8B7C-D633849DD1E7 Q33718009-83D391A6-F1EF-4E0B-94C3-43ED1C3F4B2D Q33887223-683920FD-951B-42E8-AAAF-19A7AC7BB437 Q34170893-A7A5187A-9A41-443A-BF5E-2556B35F04E6 Q34349428-BCB12E19-73CC-43A0-8E33-225F522D6560 Q34535578-60295378-F6CF-4A1D-AD65-B10B2C7F30A7 Q34676808-CE9D109A-6BC7-4011-BA5F-2168FDD42B1C Q34803950-F5A91D10-4F70-4262-B711-86781B017574 Q35256491-CF6069AC-7631-49CC-8EE3-8E918FC19EBB Q35687572-B940D3F9-E53A-420C-A396-D0E022EDC85A Q35737488-7A89765F-D147-43CE-99BD-A47814BF01C0 Q35792838-031E335C-9B1C-4502-ACE2-C44DF2977A86 Q35861206-AD290741-6D20-45FB-9745-105D5C2AB61F Q36225357-46241005-5C32-4B37-A64B-AE5024351FA6 Q36282220-C25CA289-B2B3-42A8-826B-578D8105D999 Q36523465-A8857312-9588-402A-BEE2-20D9DECFBBF7 Q36608810-5CDE03FF-C8BC-4AA4-B672-56B831B35199 Q36707530-AC296FC2-0828-42B2-BD6C-F633DEC62673 Q36958177-E4C06A9D-64BE-4C8A-82F2-29DFC527F71E Q37109618-30289FCA-3C18-49AB-8FA3-850FB4A89ACF Q37150333-38D84C58-17B5-4976-B46F-F668B0BBFB64 Q37622583-62B40CEC-3E0E-4C75-997A-1CB50FB98F6F Q37627332-EFB5CEBF-389A-4EF0-B67D-42EE53B0BB6E Q37735550-5D9FCB6C-3587-4B86-A303-47300ED112A7 Q37822830-3C66DB0B-DE6F-41D3-BD55-0C78538F6820 Q38210965-9DFB2EE6-1C25-47A7-BF42-01E046A7B592 Q38312563-9F559BC8-760E-4868-A5B4-08DE96251238 Q38378499-EEC6CB69-A23C-44F8-B65F-7EEEE581EB38 Q39889745-D85A5EFC-795A-4CB0-9A0E-BEE864511C1D Q40006848-5436D3A1-A7A4-451E-880F-36BB36134256 Q41827325-9B8C7D93-2314-4FC2-817C-02CB6F9E571E Q41928171-7E17D9E6-1A4F-43B5-B07A-8097BFD29134 Q41997705-A392A4D2-40EA-47A8-8144-6F0D2CA920C4 Q42227655-6F3A8C00-DD5D-417E-9ABF-8D636F6FB7EB Q42802160-2AAB589A-AC9B-4647-8F74-8C24E033B824 Q45399999-2C5C78D5-9FCD-4604-9944-0DADC1A70957 Q47970208-58567149-33EB-4FA9-B93B-3ABF497FBB15 Q48684091-306B055F-92E6-4756-9FE2-E88C2DFC79C0

P2860

Novel therapeutic strategy for stroke in rats by bone marrow stromal cells and ex vivo HGF gene transfer with HSV-1 vector.

http://www.wikidata.org/entity/Q48682582

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh-hant

name

Novel therapeutic strategy for ...... ne transfer with HSV-1 vector.

@en

Novel therapeutic strategy for ...... ne transfer with HSV-1 vector.

@nl

type

label

Novel therapeutic strategy for ...... ne transfer with HSV-1 vector.

@en

Novel therapeutic strategy for ...... ne transfer with HSV-1 vector.

@nl

prefLabel

Novel therapeutic strategy for ...... ne transfer with HSV-1 vector.

@en

Novel therapeutic strategy for ...... ne transfer with HSV-1 vector.

@nl

P1433

Q48682582-8E014B34-2EFF-49C2-8E91-139AE8383612

P1476

Q48682582-5BD67B5E-E987-4BFC-9681-5139CD032125

P2093

Q48682582-01AC4C08-3498-4F28-9EAD-3E606DE4C98A

Q48682582-1AE0CC32-E276-4341-9C97-546977A8E11C

Q48682582-3AE71EB2-67F3-4BF1-B664-22CD95B3912A

Q48682582-3E365C8E-BA3A-4770-BC33-C562E52C5DE1

Q48682582-58E78F43-0DB0-41D3-BF12-5B5E6722EBCC

Q48682582-76791C08-4562-4717-A67B-838C4EBF50FF

Q48682582-945A6FA2-588B-4302-978F-F48E79FEF926

Q48682582-BD0610D5-25DB-4342-A2ED-DC65E703BEAE

Q48682582-C64157EC-D87C-4EF6-BA4A-CB1014E0104D

Q48682582-CD0275EE-EAFA-46B8-ADC3-B5268080758F

P2860

Q48682582-0FEBBBC0-B29F-47DB-A8CA-74E14C13B4FC

Q48682582-155EFBEC-9D4F-4C90-A88C-F8D6D6EC9905

Q48682582-16BAA630-73DE-46A5-89BE-142DADA674FF

Q48682582-26A3594B-6890-4272-8A25-0267828E6697

Q48682582-2A443FC8-3ED3-4A6F-9864-BF586D628F22

Q48682582-365B2104-03E7-43B3-9EC4-1A5DDA1C4D17

Q48682582-374FED09-DBB6-4438-B2E0-3F9C7EF1E491

Q48682582-449C9513-9818-4AA8-B924-C442A19FE45E

Q48682582-45E831E5-0CF3-4F83-B195-BB5820BD0EDD

Q48682582-4865583D-1425-4445-B12D-B65549C8C650

P304

Q48682582-DA2C6DFB-63A1-484A-B9DE-01CDD635D186

P31

Q48682582-B33A9357-386C-4DE6-9ACF-2223EE0C3297

P356

Q48682582-FA354A12-8D4A-4358-BB5C-142619B81063

P433

Q48682582-1BEF3E5B-9C8E-4E1E-ACAB-C2928ABAEBE6

P478

Q48682582-0F8C15BD-E769-4D55-BD09-B73AB3B279F1

P50

Q48682582-56B1359D-D69D-4F10-A364-07C5A956FEDE

P577

Q48682582-C088AAEB-7FF1-4A8A-BBB0-5BDC2E2A54A4

P5875

Q48682582-F59A525C-87CD-425D-B36B-74764EEB3CAE

P698

Q48682582-D8585533-3297-464E-B371-D5785FBB8566

P356

SJ.JCBFM.9600273

P1433

Journal of Cerebral Blood Flow & Metabolism

P1476

Novel therapeutic strategy for ...... ene transfer with HSV-1 vector

@en

P2093

Daisuke Furutama

http://www.w3.org/2001/XMLSchema#string

Daisuke Miyazawa

http://www.w3.org/2001/XMLSchema#string

Hiroshi Funakoshi

http://www.w3.org/2001/XMLSchema#string

Mari Dezawa

http://www.w3.org/2001/XMLSchema#string

Masa-Aki Shibata

http://www.w3.org/2001/XMLSchema#string

Ming-Zhu Zhao

http://www.w3.org/2001/XMLSchema#string

Naokado Ikeda

http://www.w3.org/2001/XMLSchema#string

Robert S Coffin

http://www.w3.org/2001/XMLSchema#string

Shin-Ichi Miyatake

http://www.w3.org/2001/XMLSchema#string

Takuji Watanabe

http://www.w3.org/2001/XMLSchema#string

P2860

Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats

Reversible middle cerebral artery occlusion without craniectomy in rats

Immortalized multipotential mesenchymal cells and the hematopoietic microenvironment.

Differentiation of transplanted bone marrow cells in the adult mouse brain.

Lentiviral vectors: turning a deadly foe into a therapeutic agent.

Ischemic rat brain extracts induce human marrow stromal cell growth factor production.

Mesenchymal stem cells: building blocks for molecular medicine in the 21st century.

Bone marrow stromal cells as targets for gene therapy.

Treatment of neural injury with marrow stromal cells.

Toolbox for retrovectorologists.

P304

1176-1188

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.JCBFM.9600273

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P50

P577

2006-01-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7350119

http://www.w3.org/2001/XMLSchema#string

P698

16421510

http://www.w3.org/2001/XMLSchema#string